E ELAPSED TIME FROM THE FIRST OUTPATIENT VISIT TO THE DEFINITIVE TMENT IN BREAST CANCER CASES 0F PUBLIC HEALTH SYSTEM IN THE CITY 0F JUNDIAÍ

Authors

  • Edna Marina Cappi Maia Departamento de Tocoginecologia da Faculdade de Medicina de Jundiaí
  • Larissa Bulhões Maia Departamento de Tocoginecologia da Faculdade de Medicina de Jundiaí
  • Fernanda M. Valente Departamento de Tocoginecologia da Faculdade de Medicina de Jundiaí
  • Rogério Bonassi Machado Departamento de Tocoginecologia da Faculdade de Medicina de Jundiaí
  • João Bosco Ramos Borges Departamento de Tocoginecologia da Faculdade de Medicina de Jundiaí

Keywords:

Breast cancer, Diagnosis, Public Healthcare

Abstract

The study aimed to evaluate the elapsed time from the first outpatient visit in the
Health Basic Units to the surgical treatment of breast câncer in the Mastology Department, in Jundiaí, southeastern Brazil. The study included the evaluation of eighty new
cases of breast câncer that were diagnosed in 2004 retrospectively and treated in the Mastology Department of Jundiaí Public Healthcare, with analysis of the number of
time elapsed with the first outpatient visit in HBU, the execution of mammography and
ultrasonography (if necessary), biopsy and definitive surgical treatment through medicai
records, computerized data or interview. It was found that the mean time from the first
outpatient visit to the surgical treatment was 270 days. The bigger elapsed time between
the biopsy execution and the definitive surgery was about 79 days. The mammography
scheduling took about two months, and one month more to conduct the schedule to the
specialized sector. The results ratify the need of better function in Public Health System
in order to make the fiow chart service more agile, reducing the time between the breast
câncer diagnosis and treatment, improving in that way the disease prognosis.

Downloads

Download data is not yet available.

References

1.CAPLAN LS, MAY DS, RICHARDSON LC. Time to diagnosis

and treatment of breast câncer. Results from the National Breast

and Cervical Câncer Early Detection Program. Am J Public Health

2000; 90(1): 130-4.

2.FEIG SA. Current status of screening mammography. Obstet Gyn

Clin North Am 2002; 29: 123-36.

3.HACKSHAW A, PAUL E. Breast self-examination and death from

breast câncer: a meta-analysis. Br J Câncer 2003; 88: 1047-53.

6.MARINHO LAB, COSTA GURGEL MA, CECATTI JG, OSIS MJD. Conhecimento, atitude e prática do auto-exame das mamas

em centros de saúde. Rev Saúde Pública 2003; 37 (5): 576-82.

7.ROBERT A, FOSTER R, BARK W. American Câncer Society

guidelines for breast câncer screening. Update 2003. Câncer J Clin

2003; 53: 141-69.

8.ROBERTSON R, CAMPBEL NC, SMITH S. Factors influencing

time from presentation to treatment of colorectal and breast câncer

in urban and rural areas. Br J Câncer 2004; 90 (8): 1479-85.

INCA. Estimativas da incidência e mortalidade por câncer no Brasil. Rio de Janeiro: Ministério da Saúde. Secretaria Nacional de Assistência à Saúde. Instituto Nacional do Câncer. Coordenação

de Prevenção e Vigilância, 2003.

KARI H, ROGESK R, GUSTOL B. Mammographic screening is

dramatically changing age-incidence data for breast câncer. J Clin Oncol 2004; 22: 4652-3.

Published

2026-07-29

How to Cite

Maia, E. M. C., Maia, L. B., Valente, F. M., Machado, R. B., & Borges, J. B. R. (2026). E ELAPSED TIME FROM THE FIRST OUTPATIENT VISIT TO THE DEFINITIVE TMENT IN BREAST CANCER CASES 0F PUBLIC HEALTH SYSTEM IN THE CITY 0F JUNDIAÍ. Revista Brasileira De Mastologia, 16(1). Retrieved from https://mastology.org/rbm/article/view/2112

Issue

Section

Original Article